Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | EGFR | P00533 | 1/20 | 0.68 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | MMP1 | P03956 | 2/20 | 0.57 |
| ▸ | MMP2 | P08253 | 2/20 | 0.57 |
| ▸ | MMP9 | P14780 | 2/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27129868 | 1.00 | KMT2A (0.70) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL28735544 | 1.00 | KMT2A (0.70) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL31344555 | 0.99 | EGFR (0.71) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL27145242 | 0.88 | KMT2A (0.65) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL27029454 | 0.88 | KMT2A (0.65) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL31140946 | 0.88 | EGFR (0.67) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL3208177 | 0.87 | KMT2A (0.93) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL31140919 | 0.86 | KMT2A (0.70) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL31344548 | 0.86 | EGFR (0.55) | KMT2AEGFRHDAC3HDAC4HDAC1 | |
| SCHEMBL6415859 | 0.85 | KMT2A (0.90) | KMT2AEGFRHDAC3HDAC4HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346556-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-11-13 | — | — | US | claimed |
| US-12384742-B2 | Organic compounds | GIVAUDAN SA (CH) | 2025-08-12 | — | — | US | claimed |
| EP-4507522-A1 | TASTE MODIFYING COMPOSITIONS AND USES THEREOF | Firmenich SA (CH) | 2025-02-19 | — | — | EP | claimed |
| CN-119421642-A | Taste modifying composition and use thereof | 弗门尼舍有限公司 | 2025-02-11 | — | — | CN | claimed |
| WO-2023247332-A1 | TASTE MODIFYING COMPOSITIONS AND USES THEREOF | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| US-20220332675-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-10-20 | — | — | US | claimed |
| US-20250346556-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-11-13 | — | — | US | disclosed |
| US-12384742-B2 | Organic compounds | GIVAUDAN SA (CH) | 2025-08-12 | — | — | US | disclosed |
| EP-4507522-A1 | TASTE MODIFYING COMPOSITIONS AND USES THEREOF | Firmenich SA (CH) | 2025-02-19 | — | — | EP | disclosed |
| CN-119421642-A | Taste modifying composition and use thereof | 弗门尼舍有限公司 | 2025-02-11 | — | — | CN | disclosed |
| US-20240315299-A1 | AMIDE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH INCORPORATED (US) | 2024-09-26 | — | — | US | disclosed |
| EP-4307921-A1 | AMIDE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS | Firmenich Incorporated (US) | 2024-01-24 | — | — | EP | disclosed |
| WO-2023247332-A1 | TASTE MODIFYING COMPOSITIONS AND USES THEREOF | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | disclosed |
| WO-2022231918-A1 | AMIDE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS | FIRMENICH INCORPORATED (US) | 2022-11-03 | — | — | WO | disclosed |
| US-20220332675-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-10-20 | — | — | US | disclosed |
| WO-2021063942-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2021-04-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346556-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | NUDT1, OGT, AOC3 | KMT2A 876/4885EGFR 4639/4885HDAC3 3952/4885 |
| US-12384742-B2 | Organic compounds | NUDT1, CNOT9, SOST | KMT2A 577/4885EGFR 4540/4885HDAC3 2762/4885 |
| US-20220332675-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | NUDT1, OGT, AOC3 | KMT2A 897/4885EGFR 4581/4885HDAC3 3952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.